Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 2702 questions Show Answers
To ask the Scottish Executive on what date sections (a) 2, (b) 3 and (c) 6 of the Alcohol etc. (Scotland) Act 2010 will come into force and what steps it has taken to inform (i) alcohol retailers and (ii) the public.
To ask the Scottish Executive on what date Part 2 of the Alcohol etc. (Scotland) Act 2010 will come into force.
To ask the Scottish Executive what the level of sickness absence has been for inspectors employed by Social Care and Social Work Improvement Scotland, and formerly by the Care Commission and the Social Work Inspection Agency, in each month since August 2009.
To ask the Scottish Executive on what date section 5 of the Alcohol etc. (Scotland) Act 2010 will come into force and what steps it has taken to inform (a) alcohol retailers and (b) the public about this.
To ask the Scottish Executive whether it has accepted the invitation from the Department of Health to support its audit of asthma deaths so that the project can be UK wide.
To ask the Scottish Executive how many students graduated from Scottish universities with degrees in engineering in (a) 2007, (b) 2008, (c) 2009, (d) 2010 and (e) 2011.
To ask the Scottish Executive, further to the answer to question S4W-02252 by Michael Matheson on 13 September 2011, what assessment it has made of the population distribution of the 1% dietary intake of transfats.
To ask the Scottish Executive what steps it has taken to ensure that Scottish small and medium-sized software firms will be able to provide add-on software for the two primary care systems that will replace the GPASS system.
To ask the Scottish Executive, when deciding to allow prescribing of a new medicine, what steps it takes to minimise inconsistent prescribing practices across NHS boards.
To ask the Scottish Executive whether it has issued guidelines to NHS boards on the principles and timelines that should govern recommendations by area drugs and therapeutics committees (ADTCs) when reviewing new medicines approved by the Scottish Medicines Consortium and, if so, whether such guidelines deal with the (a) statement in CEL 17 (2010) on the principles determining how new medicines should be measured against other available medicines, (b) relevance of the medicine to approved treatment protocols, (c) basis on which ADTCs reject inclusion in local formularies, (d) resource and (e) service implications.